van de Laar MA - Search Results

1

Increased cardiovascular risk factors in different rheumatic diseases compared with the general population.

Meek IL, Picavet HS, Vonkeman HE, Verschuren WM, van de Laar MA. Meek IL, et al. Among authors: van de laar ma. Rheumatology (Oxford). 2013 Jan;52(1):210-6. doi: 10.1093/rheumatology/kes194. Epub 2012 Jul 30. Rheumatology (Oxford). 2013. PMID: 22847678

2

Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature.

Meek IL, Vonkeman HE, van de Laar MA. Meek IL, et al. Among authors: van de laar ma. BMC Musculoskelet Disord. 2014 Apr 29;15:142. doi: 10.1186/1471-2474-15-142. BMC Musculoskelet Disord. 2014. PMID: 24779371 Free PMC article. Review.

3

Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort.

Meek IL, Vonkeman HE, van de Laar MA. Meek IL, et al. Among authors: van de laar ma. BMC Musculoskelet Disord. 2014 May 23;15:174. doi: 10.1186/1471-2474-15-174. BMC Musculoskelet Disord. 2014. PMID: 24886363 Free PMC article.

4

Disseminated primary varicella infection during infliximab treatment.

Vonkeman H, ten Napel C, Rasker H, van de Laar M. Vonkeman H, et al. J Rheumatol. 2004 Dec;31(12):2517-8. J Rheumatol. 2004. PMID: 15570661

5

Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin.

Vonkeman H, Meek I, van de Laar M. Vonkeman H, et al. Drug Healthc Patient Saf. 2010;2:191-204. doi: 10.2147/DHPS.S7206. Epub 2010 Oct 6. Drug Healthc Patient Saf. 2010. PMID: 21701631 Free PMC article.

6

Long-term disease and patient-reported outcomes of a continuous treat-to-target approach in patients with early rheumatoid arthritis in daily clinical practice.

Versteeg GA, Steunebrink LMM, Vonkeman HE, Ten Klooster PM, van der Bijl AE, van de Laar MAFJ. Versteeg GA, et al. Clin Rheumatol. 2018 May;37(5):1189-1197. doi: 10.1007/s10067-017-3962-5. Epub 2018 Feb 1. Clin Rheumatol. 2018. PMID: 29388086 Free PMC article.

7

A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in The Netherlands.

Janssen CA, Oude Voshaar MAH, Vonkeman HE, Krol M, van de Laar MAFJ. Janssen CA, et al. Clin Rheumatol. 2018 Aug;37(8):2291-2296. doi: 10.1007/s10067-018-4127-x. Epub 2018 May 2. Clin Rheumatol. 2018. PMID: 29721712 Free PMC article.

8

Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare.

Janssen CA, Oude Voshaar MAH, Ten Klooster PM, Vonkeman HE, van de Laar MAFJ. Janssen CA, et al. Clin Rheumatol. 2019 Aug;38(8):2233-2239. doi: 10.1007/s10067-019-04566-6. Epub 2019 Apr 27. Clin Rheumatol. 2019. PMID: 31030363 Clinical Trial.

9

Understanding the NSAID related risk of vascular events.

Vonkeman HE, Brouwers JR, van de Laar MA. Vonkeman HE, et al. Among authors: van de laar ma. BMJ. 2006 Apr 15;332(7546):895-8. doi: 10.1136/bmj.332.7546.895. BMJ. 2006. PMID: 16613964 Free PMC article. Review. No abstract available.

10

Disability due to gouty arthritis.

ten Klooster PM, Vonkeman HE, van de Laar MA. ten Klooster PM, et al. Among authors: van de laar ma. Curr Opin Rheumatol. 2012 Mar;24(2):139-44. doi: 10.1097/BOR.0b013e32834ff59d. Curr Opin Rheumatol. 2012. PMID: 22227879 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

276 results

Search Page